June 2026
1. KALVELAGE L, Casteel M, Hartmann M, Harder TC, et al
   Environmental samples, a sensitive and practical alternative to individual bird sampling in the surveillance of H9N2 vaccinated turkey flocks.
   J Gen Virol. 2026;107:002279.
   

   >> Share

   
   April 2026
2. CHIANG HL, Lin HT, Chen WY, Liang KH, et al
   Broadly neutralizing monoclonal antibodies derived from mRNA LNP immunization exhibit potent neutralizing ability against JN.1, KP.3.1.1 and XEC new Omicron variants.
   J Gen Virol. 2026;107:002251.
   

   >> Share

   
   March 2026
3. DISLERS A, Nilova O, Jansons J, Skrastina D, et al
   Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvant.
   J Gen Virol. 2026;107:002240.
   

   >> Share

   
   February 2026
4. SAITO H, Midorikawa Y, Okamura T, Mwamburi SM, et al
   Attenuation mechanisms of the P7-P8 live-attenuated cyvirus cyprinidallo2 vaccine potentially involve apoptosis non-inhibition feature: insights into virus pathogenesis.
   J Gen Virol. 2026;107:002227.
   

   >> Share

   
   January 2026
5. MIMMS JL, Sinnis-Bourozikas A, Felbinger NR, Frumento N, et al
   Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent.
   J Gen Virol. 2026;107:002201.
   

   >> Share

   
   
6. SABSABI MA, Kheimar A, von La Roche D, Hartle S, et al
   Role of gammadelta T cells in turkey herpesvirus vaccine protection against Marek's disease virus.
   J Gen Virol. 2026;107:002204.
   

   >> Share

   
   November 2025
7. OHRNBERGER S, Meyer Zu Natrup C, Clever S, Schunemann LM, et al
   Strong immunogenicity and protection against SARS-CoV-2 in hamsters induced by heterologous boost vaccination with an MVA-based COVID-19 vaccine candidate.
   J Gen Virol. 2025;106:002180.
   

   >> Share

   
   
8. ENTRIKEN CG, Bruce KL, Coyne BM, Kruyer SH, et al
   Improved efficacy of an influenza DNA vaccine through high-density microarray patch delivery.
   J Gen Virol. 2025;106:002179.
   

   >> Share

   
   October 2025
9. DVORAK M, Arbon D, Salat J, Fortova A, et al
   Sex-dependent impairment of antibody responses to tick-borne encephalitis virus vaccination and infection in obese mice.
   J Gen Virol. 2025;106:002161.
   

   >> Share

   
   
10. PFRANGER M, Krause N, Asbach B, Meier J, et al
    Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccine.
    J Gen Virol. 2025;106:002157.
    

    >> Share

    
    
11. DVORAK M, Arbon D, Salat J, Fortova A, et al
    Erratum: Sex-dependent impairment of antibody responses to tick-borne encephalitis virus vaccination and infection in obese mice.
    J Gen Virol. 2025;106:002171.
    

    >> Share

    
    September 2025
12. PONSARD C, Chasseur AS, Lombard P, Danneels B, et al
    Conserved and distinct expression of circular RNAs in commercially used Marek's disease vaccine viruses.
    J Gen Virol. 2025;106.
    

    >> Share

    
    
13. TSCHERNE A, Kalodimou G, Jany S, Freudenstein A, et al
    Robust polyfunctional CD8(+) and CD4(+) T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein.
    J Gen Virol. 2025;106.
    

    >> Share

    
    July 2025
14. HIRST JC, Napier A, Burbidge D, Scott K, et al
    Glycan site loss in two egg-adapted live attenuated influenza vaccine strains does not cause antigenic mismatches.
    J Gen Virol. 2025;106.
    

    >> Share

    
    May 2025
15. AHMED MN, Abu Habib US, Abdallah AM, Emara MM, et al
    The impact of pre-existing immunity on the emergence of within-host immune-escape mutations in Omicron lineages.
    J Gen Virol. 2025;106:002108.
    

    >> Share

    
    April 2025
16. SANCHEZ-MARTINEZ A, Moore T, Freitas TS, Benzaken TR, et al
    Recent advances in the prevention and treatment of respiratory syncytial virus disease.
    J Gen Virol. 2025;106.
    

    >> Share

    
    January 2025
17. LIU X, Yu J, Li S, Chai P, et al
    An improved reverse genetics system for rotavirus vaccine strain LLR using five plasmid vectors.
    J Gen Virol. 2025;106.
    

    >> Share

    
    June 2024
18. DEE K, Manali M, Bissett LA, Bone J, et al
    Smallpox vaccination campaigns resulted in age-associated population cross-immunity against monkeypox virus.
    J Gen Virol. 2024;105.
    

    >> Share

    
    April 2024
19. ZHANG J, Cui L, Zhang Y, Pan H, et al
    Oral administration of PEDV-dissolved Alg-CS gel induces high and sustained mucosal immunity in mice.
    J Gen Virol. 2024;105.
    

    >> Share

    
    March 2024
20. BAI W, Zhu Q, Wang J, Jiang L, et al
    Licorice extract inhibits porcine epidemic diarrhea virus in vitro and in vivo.
    J Gen Virol. 2024;105.
    

    >> Share

    
    
21. SAMOLEJ J, White IJ, Strang BL, Mercer J, et al
    Cardiac glycosides inhibit early and late vaccinia virus protein expression.
    J Gen Virol. 2024;105.
    

    >> Share

    
    February 2024
22. RAO S, Erku D, Mahalingam S, Taylor A, et al
    Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials.
    J Gen Virol. 2024;105.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share